Cisplatin, Docetaxel, and Pembrolizumab in Treating Patients With Stage II-III Laryngeal Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Mayo Clinic
Massachusetts General Hospital
Sun Yat-sen University
National Institutes of Health Clinical Center (CC)
ImmunityBio, Inc.
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
Gilead Sciences
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
GERCOR - Multidisciplinary Oncology Cooperative Group
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Sun Yat-sen University
Sir Run Run Shaw Hospital
City of Hope Medical Center
Hospital of Stomatology, Wuhan University
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
The University of Texas Health Science Center at San Antonio
Sun Yat-sen University
Sun Yat-sen University
Sun Yat-sen University
AIO-Studien-gGmbH
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Groupe Oncologie Radiotherapie Tete et Cou
Arbeitsgemeinschaft medikamentoese Tumortherapie
China Three Gorges University, Yichang, China
Wake Forest University Health Sciences
Barbara Ann Karmanos Cancer Institute
Radiation Therapy Oncology Group
European Organisation for Research and Treatment of Cancer - EORTC
Masonic Cancer Center, University of Minnesota
Dana-Farber Cancer Institute
Emory University
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Lithuanian University of Health Sciences
Case Comprehensive Cancer Center
University of Leipzig
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Dana-Farber Cancer Institute
SWOG Cancer Research Network
National Cancer Institute (NCI)
Vanderbilt-Ingram Cancer Center
SWOG Cancer Research Network
National Cancer Institute (NCI)
Dana-Farber Cancer Institute